Pu and slightly soluble 238 Pu. The MDA, precision and bias for 239 Pu and 238 Pu met the performance criteria. The performance statistics reported by GEL for 239 Pu and 238 Pu also met the acceptance criterion. There were no reported failed analyses but 3% of fecal analyses were flagged for low yield (less than 50%) or high yield (greater than 110%), which is within the contractual level of 10%. Overall the plutonium fecal analyses were considered acceptable.
The 241 Am fecal and urine analyses met the acceptance criteria for MDA, relative bias and precision. The MDA as reported by GEL was less than 5% of the contractual level. All 23 of the 241 Am samples spiked at the contractual detection level (CDL) were detected. Out of 367 samples spiked by GEL at the CDL, 10 samples did not show detection, giving a false-negative (beta error) of 3%, which was acceptable. The relative bias and precision as reported by GEL and tested by IDP met the performance criteria. The current AM241 urinalysis procedure was considered acceptable. The first 4 samples were analyzed using the current procedure of pre-concentrating the actinides by precipitation prior to the destruction of organics. All the samples showed detection for 239 Pu and 241 Am. The plutonium yields with this procedure averaged 86%, however, the yields for the americium analysis were only 40%, with a range of 31% -54%. The remaining 4 samples were analyzed under a revised procedure where destruction of the organic material was performed prior to the pre-concentration of the actinides. Using the revised procedure the yield recovery for the plutonium analysis continued to be acceptable at 86% but there was a significant improvement in the americium analysis with an average yield of 97.5%.
To ensure that tracer yields meet the criteria, the standard procedure was revised to state that if a sample contains DTPA that the destruction of the organic material is to be performed prior to the pre-concentration of the actinides.
The AM243 procedure was identical to the AM241 procedure, except a different tracer is used ( 244 Cm instead of 243 Am). Only one of the seven blank 243 Am QC samples submitted showed detection resulting in a false-positive (alpha error) of 14%, which met acceptance criteria, assuming the normal statistical variation in the measurement process. The calculated MDA slightly exceeded the contractual detection level as tested by IDP and GEL each quarter as well as in the annual. The trend towards a slightly elevated MDA for the AM243 procedure was not addressed in GEL's annual report. The performance statistics for 243 Am, as tested by GEL, met the acceptance criteria for relative bias and precision. Because the MDA was only slightly elevated the 243 Am procedure was concluded to be acceptable but it will be re-evaluated during the 2012 annual audit of GEL.
IDP submitted 5 blank samples for isotopic curium analysis. .30 (1996) and are listed in the Statement of Work. In addition to the Statement of Work (SOW) performance criteria, it is expected that the MDA shall also be such that fewer than 10% of the QC samples spiked at the CL shall be reported with values less than the decision level (i.e., twice the total propagated uncertainty of the result).
METHODS

GENERAL METHODS
Urine collected from PNNL employees who are not occupationally exposed to radioactive program, plutonium, americium, and strontium analyses were tested using routine sequential procedures when possible (i.e., where one urine sample is analyzed for several radionuclides).
The analysis categories specified in the contract with GEL are shown in Table 1 . All urinalysis samples contained approximately 1000 ml of urine, except for the samples analyzed for tritium, which contained approximately 100 ml. GEL's QC sample total is dependent on the number of analytical batches run during the year, and they were well over the 15% criteria specified in the contract. GEL's performance was checked by determining detection level, bias, and precision based on the results of blank and spiked samples. Spiked samples fell into two categories: those spiked near the CL and those spiked at equal to or greater than three times the CL. These two categories were necessary to check compliance with the criteria for relative precision (S B )
specified by the Statement of Work. Satisfying these two categories also verified that GEL could detect sample activities near the CL.
DETECTION LEVELS
Various mathematical expressions and terminology can be used to describe a detection level. The statistical approach specified in the Statement of Work basically follows that of Currie (1968) and HPS N13.30 (HPS 1996) . However, the HPS N13.30 formulas were modified to account for the difference between a priori estimates of detection levels based on counts (Currie 1968 ) and a posteriori estimates based on total activity, where chemical yield is determined specifically for each sample.
Two test criteria were used: the decision level (L c ) and the MDA (also called the detection level). The decision level was defined in the Statement of Work as the quantity of radioactivity or mass above which there is at least 95% confidence that the sample is not a blank (Type I error). If the measured value was greater than the L c , the sample was considered likely to contain the radionuclide of interest. If the measured value was less than L c , then the result was considered indistinguishable from a blank. The L c was determined solely by measuring blank samples. Before the L c was calculated, results that were significant outliers were eliminated from the data set. Outliers were identified by the use of the criteria of ASTM E178-94 (ASTM 1994).
Mathematically, L c is defined by the following equation:
where, s A equals the combined standard uncertainty of the net analyte reported.
The MDA was based on a 95% probability of detecting activity when the actual activity is equal to the MDA, and conversely a 5% probability of the results falling below the L c and being judged to contain no activity (Type II error). The MDA, expressed in units of disintegrations per minute, is calculated from the same set of blanks as the L c (outliers excluded), using the GEL also uses synthetic samples, whereas IDP uses real fecal and urine samples.
The IDP QC samples were evaluated by first calculating the L c from blank samples, excluding outliers. This L c was compared with the L c calculated from GEL's own QC samples.
Then, the MDA was calculated and compared with the CL and the MDA calculated from GEL's own QC samples. Values used for E, R, and T in the MDA equation were obtained from the laboratory; they are listed in Table 3 . Finally, the percentage of QC samples spiked at the CL that were measured by the laboratory as having less than the decision level (i.e., no activity was detected) was determined; this percentage was then compared with the 5% allowed in the Statement of Work. Outliers were included in this test. Outliers were excluded from the test, but not ignored for the procedure evaluation. As stipulated in the Statement of Work, the mean relative bias shall fall within ± 20% when calculated from 15 to 50 spiked samples, and within  10% when calculated from over 50 samples.
PRECISION
The precision statistic used for this contract was S B from HPS N13. 30 (1996) , but the limits differ from that standard. S B is given by:
where the symbols are the same as for relative bias (B r ).
The above equation is valid for samples spiked at one or more levels, subject to the limits for the relative precision, which depend on the activity of the spikes relative to the CL.
Specifically, the relative precision statistics shall be less than or equal to 0.4 for samples spiked greater than three times the CL and less than or equal to 0.5 for samples spiked between one and three times the CL. Outliers were not included in the determination of precision. The results of the statistical tests (see Table 4 and Appendix A) are discussed below. Statistical results from the present and previous years are compared in Table 5 .
OUTLIERS
Analytical results that are biased by "blunders" during the analysis should not be included in the data set used for the statistical evaluation of the analytical procedure, but too many outliers would indicate poor laboratory performance (see Table 6 ). GEL (see Appendix B) identified some outliers associated with their laboratory control samples (blanks and spiked). In future QC reports GEL has been asked not to classify QC data points as outliers and remove them from the database if the result was a statistical anomaly. However, if there was a laboratory error resulting in an erroneous result, then the associated data can be excluded from the performance statistics.
Any outliers removed from the data tables need to be addressed in the observation section. 
STRONTIUM-90 AND TOTAL STRONTIUM
The total strontium procedure is used to screen samples to determine whether analysis for Pu and 239 Pu were analyzed using the same procedures and same reagents.
The two isotopes are differentiated only at the end of the procedure by alpha spectrometry. Therefore, laboratory performance is expected to be similar for both isotopes using any of the seven procedures that incorporate plutonium analysis (IPU, IPA, IPS, IPSA, IPSR, IUPU, and ITPAC). Pu and 238 Pu also met the acceptance criterion. There were no reported failed analyses but 3% of fecal analyses were flagged for low yield (less than 50%) or high yield (greater than 110%), which is within the contractual level of 10%. Overall the plutonium fecal analyses were considered acceptable.
ISOTOPIC URANIUM
The isotopic uranium analysis reports on three uranium isotopes: 234 U, 235 U, and 238 U. The isotopes are differentiated only during counting by alpha spectrometry. The MDA reported by the lab for 234 U and 238 U were elevated and they did not meet the contractual detection level and the MDA reported for 235 U was at the contractual level. It was assumed that there were environmental contaminants; however, the analysis will be further reviewed in the 2012 audit of the lab. All performance criteria were met within statistical variation. Of the 81 samples that GEL spiked at the CDL, all showed detection, and the 18 samples spiked by IDP at the environmental screening level likewise all showed detection.
Because IDP used a depleted uranium source material for the isotopic uranium urinalyses, 233,234 U was not evaluated. However, the performance statistics for 235 U and 238 U were reviewed and the MDA for 235 U and the bias and precision for 238 U were acceptable.
URANIUM MASS
No concerns were identified with the 238 U mass urinalysis program using inductivelycoupled plasma mass spectrometry (ICPMS) and it was considered acceptable. Because IDP uses a 0.2 µg screening level for 238 U mass, samples spiked at 0.06 µg were discontinued. The MDA at the contractual level of 0.06 µg was evaluated through GEL's program and was found to be acceptable. The relative bias and precision were likewise acceptable. The bias and precision as tested by IDP met the acceptance criteria. The bias and precision was tested by IDP at 0.2 µg and by GEL at 1 µg/sample and at 0.05 µg/sample.
URANIUM-236 VIA INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY (ICPMS)
The performance statistics for the 236 U analysis using ICPMS were not evaluated since no samples were submitted during the second contract year.
AMERICIUM-241
The 241 Am urine analyses met the acceptance criteria for MDA, relative bias and precision. The MDA as reported by GEL was less than 5% of the contractual level. All 23 of the 241 Am samples spiked at the contractual detection level (CDL) were detected. Out of 367 samples spiked by GEL at the CDL, 10 samples did not show detection, giving a false-negative (beta error) of 3%, which was acceptable.
The relative bias and precision as reported by GEL and tested by IDP met the performance criteria. The current AM241 urinalysis procedure was considered acceptable. Overall the results met the acceptance criteria and the isotopic thorium urinalysis program was considered acceptable.
NEPTUNIUM-237
Neptunium-237 was likewise not tested by IDP and the performance statistics were supplied by GEL's QC program. Because only 4 routine samples were submitted for analysis there were less than 9 total QC samples analyzed by GEL. The average relative bias met the acceptance criteria, however, the MDA and relative precision did not. Because there were only 9 QC samples analyzed by GEL (3 blank samples, 3 at the CL, and 3 to evaluated relative bias and precision) the uncertainty inherent in the measurement process precluded accurate evaluation of the performance criteria. The NP237 analysis will be reviewed during the 2012 annual audit of GEL and it will continue to be monitored. The first 4 samples were analyzed using the current procedure of pre-concentrating the actinides by precipitation prior to the destruction of organics. All the samples showed detection for 239 Pu and 241 Am. The plutonium yields with this procedure averaged 86%, however, the yields for the americium analysis were only 40%, with a range of 31% -54%. The remaining 4 samples were analyzed under a revised procedure where destruction of the organic material was performed prior to the pre-concentration of the actinides. Using the revised procedure the yield recovery for the plutonium analysis continued to be acceptable at 86% but there was a significant improvement in the americium analysis with an average yield of 97.5%.
ANALYSIS OF URINE SAMPLES CONTAINING
To ensure that tracer yields meet the criteria, the standard procedure was revised to state that if a sample contains DTPA that the destruction of the organic material is to be performed prior to the preconcentration of the actinides.
FOLLOW-UP ON CONCERNS DURING THE FIRST 112512 CONTRACT YEAR
There were a few concerns carried over from the first contract year, primarily an increasing low and high yield rate seen in the isotopic plutonium and americium-241 analyses for both fecal and urine, in the isotopic uranium analysis and with the strontium analysis. In the statement of work, table B-10 outlines the criteria for flagging samples for low or high tracer yields and for designating an analysis as failed due to tracer yield concerns. During the second contract year the percent of flagged yield samples declined in all categories with the exception of isotopic curium urinalyses, which increased to 2.2% from 1.1%. The yield flags and failed analysis rate will continue to be monitored but the concern from the first contract year was sufficiently addressed by the lab. GEL reported all analytical batches were analyzed with a reagent blank (Umass only), matrix blank or both. GEL considered blanks in control when the calculate MDA was less than the Contract Limit (CL) and the L c was less than ½ CL (see Appendix B). In addition, the chemical tracer yields were evaluated against the yield requirements stated in the subject contract. Overall, GEL believed that the blank and spike data for each analytical process demonstrated that the analyses were in control.
In the review GEL indentified laboratory control samples that had yields greater than 125% as well as one excreta sample that had a tracer yield greater than 125%. GEL also indentified laboratory control samples that met the criteria for low yield, but likewise a review of excreta sample results found the low yield rate to be acceptable. The urine sampling program showed acceptable levels for tracer yields for all analyses. The isotopic plutonium urinalysis program showed the highest yield flag rate at 5%, which is below the 10% level for follow-up. In 2011 GEL participated in the PROCORAD intercomparison program for carbone-14 in urine phosphate precipitation. 5. Chemical separations are performed via ion exchange or organic extraction. 6. Analytes are then prepared for alpha spectrometry counting using a rare earth fluoride coprecipitation.
RESULTS FROM INTERCOMPARISON PROGRAMS
The remaining 4 samples were analyzed under the revised procedure and the yield recovery for the plutonium analysis continued to be acceptable at 86% but there was a significant improvement in the americium analysis with an average yield of 97.5%. The MDA was evaluated for 238 Pu, and it was acceptable at less than 48% of the required detection level. The relative bias and precision for 239 Pu and 241 Am were likewise acceptable based on the analysis results of all 8 samples. However, to ensure that tracer yields meet the criteria, a revision to the current procedure was made stating that if a sample contains DTPA that the destruction of the organic material is to be performed prior to the pre-concentration of the actinides.
CONCLUSION:
DTPA complexes are slow to decompose and without completely destroying the organic material the DTPA complexes will not be pre-concentrated in the calcium phosphate precipitate. In addition, americium is more tenaciously bound to DTPA than plutonium at pH 2.
CHANGES IN THE APPROACH TO ANALYZE BIOASSAY SAMPLES CONTAINING DTPA
Destruction of organic material will need to be performed prior to preconcentration of sample for samples containing DTPA. The lab will need to be notified of bioassay samples containing DTPA so they could implement the revised procedure. Samples not containing DTPA will continue to be analyzed using the routine monitoring procedures.
For small sample volumes this would not impact processing times, however, larger sample volumes will take longer to process. Priority processing turnaround times should not be affected but longer processing times will be expected for Emergency and Expedite processing.
